Mosley Wealth Management’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-37
Closed -$1.44K 815
2026
Q1
$1.44K Buy
+37
New +$1.88K ﹤0.01% 407

Other funds holding SBIO

Mosley Wealth Management's SBIO Position: Q2 2026 in Review

Mosley Wealth Management sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q2 2026, closing a stake of 37 shares — an estimated $1.44K sold.

Mosley Wealth Management first reported a position in SBIO in Q1 2026 and held it in 1 quarter. The position peaked at $1.44K in Q1 2026. 33 funds tracked by Wall St. Rank hold SBIO as of Q2 2026.

  • Mosley Wealth Management reported no remaining ALPS Medical Breakthroughs ETF position as of Q2 2026 after selling out during the quarter.
  • Mosley Wealth Management sold 37 ALPS Medical Breakthroughs ETF shares in Q2 2026, an estimated $1.44K.
  • Mosley Wealth Management first reported a position in ALPS Medical Breakthroughs ETF in Q1 2026 and held it in 1 quarter.
  • Mosley Wealth Management's ALPS Medical Breakthroughs ETF position peaked at $1.44K in Q1 2026.
  • 33 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2026.

Based on Mosley Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.